N-3-[18F]fluoropropyl-2β-carbomethoxy-3β-4-iodophenyl nortropane ([18F]FP-CIT) is a radiopharmaceutical for dopaminetransporter (DAT) imaging using positron emission tomography (PET) to detect dopaminergic neuronal degeneration inpatients with parki...
N-3-[18F]fluoropropyl-2β-carbomethoxy-3β-4-iodophenyl nortropane ([18F]FP-CIT) is a radiopharmaceutical for dopaminetransporter (DAT) imaging using positron emission tomography (PET) to detect dopaminergic neuronal degeneration inpatients with parkinsonian syndrome. [18F]FP-CIT was granted approval by the Ministry of Food and Drug Safety in 2008as the inaugural radiopharmaceutical for PET imaging, and it has found extensive utilization across numerous institutions inKorea. This review article presents an imaging procedure for [18F]FP-CIT PET to aid nuclear medicine physicians in clinicalpractice and systematically reviews the clinical studies associated with [18F]FP-CIT PET.